Madrigal Pharmaceuticals
MDGL
Last Price
52 Week Range
$265.00 - $615.00
Next Earnings Date
May 07 2026
Next Earnings Date
May 07 2026
Last Price
Madrigal Pharmaceuticals SEC Filings
Company Name | Form Type | Filed | View |
|---|---|---|---|
Madrigal Pharmaceuticals, Inc. | 10-K | February 19, 2026 | |
Madrigal Pharmaceuticals, Inc. | 8-K | February 19, 2026 | |
Madrigal Pharmaceuticals, Inc. | 8-K | January 30, 2026 | |
Madrigal Pharmaceuticals, Inc. | 8-K | December 11, 2025 | |
Madrigal Pharmaceuticals, Inc. | 10-Q | November 4, 2025 | |
Madrigal Pharmaceuticals, Inc. | 8-K | November 4, 2025 | |
Madrigal Pharmaceuticals, Inc. | 8-K | August 5, 2025 | |
Madrigal Pharmaceuticals, Inc. | 10-Q | August 5, 2025 | |
Madrigal Pharmaceuticals, Inc. | 8-K | July 30, 2025 | |
Madrigal Pharmaceuticals, Inc. | 8-K | July 22, 2025 | |
Madrigal Pharmaceuticals, Inc. | 8-K | June 20, 2025 | |
Madrigal Pharmaceuticals, Inc. | 8-K | May 1, 2025 | |
Madrigal Pharmaceuticals, Inc. | 10-Q | May 1, 2025 | |
Madrigal Pharmaceuticals, Inc. | ARS | April 29, 2025 | |
Madrigal Pharmaceuticals, Inc. | DEF 14A | April 29, 2025 | |
Madrigal Pharmaceuticals, Inc. | DEFA14A | April 29, 2025 | |
Madrigal Pharmaceuticals, Inc. | 8-K | April 17, 2025 | |
Madrigal Pharmaceuticals, Inc. | 8-K | March 11, 2025 | |
Madrigal Pharmaceuticals, Inc. | 8-K | February 26, 2025 | |
Madrigal Pharmaceuticals, Inc. | 10-K | February 26, 2025 | |
Madrigal Pharmaceuticals, Inc. | 8-K | January 13, 2025 | |
Madrigal Pharmaceuticals, Inc. | 10-Q | October 31, 2024 | |
Madrigal Pharmaceuticals, Inc. | 8-K | October 31, 2024 | |
Madrigal Pharmaceuticals, Inc. | 8-K | August 7, 2024 | |
Madrigal Pharmaceuticals, Inc. | 10-Q | August 7, 2024 | |
Madrigal Pharmaceuticals, Inc. | 8-K | June 27, 2024 | |
Madrigal Pharmaceuticals, Inc. | 8-K | May 7, 2024 | |
Madrigal Pharmaceuticals, Inc. | 8-K | May 7, 2024 | |
Madrigal Pharmaceuticals, Inc. | 10-Q | May 7, 2024 | |
Madrigal Pharmaceuticals, Inc. | S3ASR | May 7, 2024 |
Load More...
Gainify
Features
Platform
Resources
Learn
Socials
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.
© 2026 Gainify. All rights reserved.